1eye wrote:
Thanks to cheerleader, we knew about Dr. Fox's work, as soon as it was published. That's one good thing about this place. There almost seems to be a competition to get the best info. I think it's great. The ISNVD interview I found the most earth-shaking was Dr. Alexander's, where he said they have markers for MS that are related to vascular remodeling, involving the state of the endothelium in the veins. To me it was an unexpected deepening of the theoretical side, strengthening the CCSVI theory.
Thanks, one eye. Not so sure it was about competition for best info....I've always been on the quest to help Jeff feel better. And to make sure my son doesn't get this wretched disease. Urging researchers to follow up on this line of inquiry is why I'm still posting...we need these brilliant minds working together, and we need the interested parties to help do the urging and funding of these events.
Dr. J. Steven Alexander has been looking at the vascular connection in MS since since the early 2000s. I got to sit with him and discuss the endothelium at the first Bologna conference in September 2009. He was particularly interested in my noticing Jeff's high serum markers for inflammation and coagulation during his first flare, and linking that to endothelial dysfunction, as that was/is his line of investigation-- Endothelial microparticles in the blood of pwMS. He was reading the TIMS boards back in '08, and knew me as Cheerleader. Not sure if he's still checking in....but if so---"THANKS, Dr. Alexander!!"
http://www.isnvd.org/files/bios/Alexander.pdf Quote:
Dr. Alexander is an endothelial and vascular biologist working on how microvascular injury associated with forms of neuroinflammation (Multiple Sclerosis, stroke, Alzheimer’s disease), cancer and Crohn's disease. All of these diseases exhibit disturbances in blood vessel barrier function contributing to tissue edema. Current models indicate that endothelial activation, survival and junctional integrity (tight and adherens junctions) are metabolically regulated and modulate solute and inflammatory cell extravasation during inflammation. A new and important direction in this area of research is the understanding of the significance of endothelial microparticles as predictive markers and mediators of acute and chronic BBB inflammation, particularly in MS and AD.
cheer
_________________
Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
dual stents placed 5/09
CCSVI in MS